Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications

被引:1
|
作者
Cheng, Shizhou [1 ]
Zhang, Shu [1 ]
Huang, Mingyan [1 ]
Liu, Yuxuan [1 ]
Zou, Xunyu [1 ]
Chen, Xiaoming [1 ]
Zhang, Zuhai [1 ]
机构
[1] Yangtze Univ, Dept Ophthalmol, Affiliated Hosp 1, Jingzhou, Peoples R China
关键词
neovascular age-related macular degeneration; vascular endothelial growth factor; treatment; mechanism; clinical application; INTRAVITREAL AFLIBERCEPT INJECTION; RANIBIZUMAB; THERAPY; VEGF; ANGIOGENESIS; OUTCOMES; PHARMACOKINETICS; CLASSIFICATION; DISCOVERY; HISTORY;
D O I
10.3389/fmed.2024.1411278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neovascular age-related macular degeneration (nARMD) is an important cause of visual impairment and blindness in the elderly, with choroidal neovascularization in the macula as the main pathological feature. The onset of nARMD is closely related to factors including age, oxidative stress, and lipid metabolism. Vascular endothelial growth factor (VEGF) is an important factor contributing to nARMD as well as choroidal neovascularization and retinal leakage formation. At present, anti-VEGF therapy is the only treatment that improves vision and halts disease progression in most patients, making anti-VEGF drugs a landmark development for nARMD treatment. Although intravitreal injection of anti-VEGF drugs has become the first-line treatment for nARMD, this treatment has many shortcomings including repeated injections, poor or no response in some patients, and complications such as retinal fibrosis. As a result, several new anti-VEGF drugs are being developed. This review provides a discussion of these new anti-VEGF drugs for the treatment of nARMD.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Vascular remodelling after treatment with intravitreal anti-vascular endothelial growth factor in patients with neovascular age-related macular degeneration
    Kirkova, Radina
    Murgova, Snezhana
    Tanev, Ivan
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [22] Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
    Upasani, Deepa
    Dhingra, Narendra
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (09) : 2350 - 2354
  • [23] Anti-Vascular Endothelial Growth Factor Treatment Discontinuation and Interval in Neovascular Age-Related Macular Degeneration in the United States
    Bakri, Sophie J.
    Karcher, Helene
    Andersen, Stefen
    Souied, Eric H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 242 : 189 - 196
  • [24] Treatment satisfaction of patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents
    Theodoros P. Marakis
    Chrysanthi Koutsandrea
    Klio I. Chatzistefanou
    Yannis Tountas
    International Ophthalmology, 2018, 38 : 565 - 576
  • [25] Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function
    Neffendorf, James E.
    Mare, Tracey
    Simpson, Andrew R. H.
    Soare, Cristina
    Kirthi, Varo
    Sharpe, Claire C.
    Jackson, Timothy L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (07) : 1770 - 1772
  • [26] Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
    Mantel, Irmela
    Borgo, Angelica
    Guidotti, Jacopo
    Forestier, Edwige
    Kirsch, Olga
    Derradji, Yasmine
    Waridel, Patrice
    Burdet, Frederic
    Mehl, Florence
    Schweizer, Claude
    Roduit, Raphael
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [27] Treatment satisfaction of patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents
    Marakis, Theodoros P.
    Koutsandrea, Chrysanthi
    Chatzistefanou, Klio I.
    Tountas, Yannis
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (02) : 565 - 576
  • [28] Development of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration During Anti-Vascular Endothelial Growth Factor Treatment
    Cho, Han Joo
    Yoon, Wontae
    Yoon, Jihyun
    Na, Seung Kwan
    Lee, Jihyun
    Kim, Jaemin
    Kim, Chul Gu
    Kim, Jong Woo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 234 : 6 - 14
  • [29] Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Dhingra, Narendra
    Upasani, Deepa
    Ghanchi, Faruque
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (06) : 2065 - 2070
  • [30] Macular capillary plexuses during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration
    Hikichi, Taiichi
    Agarie, Mitsuko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)